Rua Life Sciences akcijos akcijų analizė | Akcijų kaina | Naujienos | RUA.L | GB0033360586 | 121857

Data	Rua Life Sciences Pajamos	Rua Life Sciences EBIT	Rua Life Sciences Pelnas
2026e	4,43 mln. undefined	412 000,00 undefined	447 454,75 undefined
2025e	3,40 mln. undefined	−1,15 mln. undefined	−958 831,60 undefined
2024e	2,29 mln. undefined	−2,14 mln. undefined	−2,78 mln. undefined
2023	2,18 mln. undefined	−2,31 mln. undefined	−2,00 mln. undefined
2022	1,63 mln. undefined	−2,35 mln. undefined	−2,07 mln. undefined
2021	1,53 mln. undefined	−1,55 mln. undefined	−1,45 mln. undefined
2020	490 000,00 undefined	−940 000,00 undefined	−820 000,00 undefined
2019	460 000,00 undefined	−630 000,00 undefined	−610 000,00 undefined
2018	400 000,00 undefined	−290 000,00 undefined	−30 000,00 undefined
2017	470 000,00 undefined	−190 000,00 undefined	−180 000,00 undefined
2016	500 000,00 undefined	−330 000,00 undefined	−400 000,00 undefined
2015	520 000,00 undefined	−150 000,00 undefined	−230 000,00 undefined
2014	260 000,00 undefined	−430 000,00 undefined	−820 000,00 undefined
2013	200 000,00 undefined	−760 000,00 undefined	−540 000,00 undefined
2012	3,16 mln. undefined	500 000,00 undefined	40 000,00 undefined
2011	1,57 mln. undefined	−2,14 mln. undefined	−2,50 mln. undefined
2010	1,36 mln. undefined	−2,06 mln. undefined	−1,92 mln. undefined
2009	1,26 mln. undefined	−1,54 mln. undefined	−1,25 mln. undefined
2008	1,48 mln. undefined	−1,37 mln. undefined	−1,16 mln. undefined
2007	280 000,00 undefined	−2,23 mln. undefined	−2,12 mln. undefined
2006	1,43 mln. undefined	−670 000,00 undefined	−520 000,00 undefined
2005	140 000,00 undefined	−2,08 mln. undefined	−1,87 mln. undefined
2004	360 000,00 undefined	−2,19 mln. undefined	530 000,00 undefined

	Pajamos	EBIT	Pelnas
2004	360 000,00 GBP	−2,19 mln. GBP	530 000,00 GBP
2005	140 000,00 GBP	−2,08 mln. GBP	−1,87 mln. GBP
2006	1,43 mln. GBP	−670 000,00 GBP	−520 000,00 GBP
2007	280 000,00 GBP	−2,23 mln. GBP	−2,12 mln. GBP
2008	1,48 mln. GBP	−1,37 mln. GBP	−1,16 mln. GBP
2009	1,26 mln. GBP	−1,54 mln. GBP	−1,25 mln. GBP
2010	1,36 mln. GBP	−2,06 mln. GBP	−1,92 mln. GBP
2011	1,57 mln. GBP	−2,14 mln. GBP	−2,50 mln. GBP
2012	3,16 mln. GBP	500 000,00 GBP	40 000,00 GBP
2013	200 000,00 GBP	−760 000,00 GBP	−540 000,00 GBP
2014	260 000,00 GBP	−430 000,00 GBP	−820 000,00 GBP
2015	520 000,00 GBP	−150 000,00 GBP	−230 000,00 GBP
2016	500 000,00 GBP	−330 000,00 GBP	−400 000,00 GBP
2017	470 000,00 GBP	−190 000,00 GBP	−180 000,00 GBP
2018	400 000,00 GBP	−290 000,00 GBP	−30 000,00 GBP
2019	460 000,00 GBP	−630 000,00 GBP	−610 000,00 GBP
2020	490 000,00 GBP	−940 000,00 GBP	−820 000,00 GBP
2021	1,53 mln. GBP	−1,55 mln. GBP	−1,45 mln. GBP
2022	1,63 mln. GBP	−2,35 mln. GBP	−2,07 mln. GBP
2023	2,18 mln. GBP	−2,31 mln. GBP	−2,00 mln. GBP
2024e	2,29 mln. GBP	−2,14 mln. GBP	−2,78 mln. GBP
2025e	3,40 mln. GBP	−1,15 mln. GBP	−958 831,60 GBP
2026e	4,43 mln. GBP	412 000,00 GBP	447 454,75 GBP

Rua Life Sciences Bruto marža	Rua Life Sciences Pelnas-martža	Rua Life Sciences EBIT marža	Rua Life Sciences Pelnas-martža
2026e	82,19 %	9,30 %	10,10 %
2025e	82,19 %	−33,79 %	−28,21 %
2024e	82,19 %	−93,20 %	−121,32 %
2023	82,19 %	−105,83 %	−91,92 %
2022	83,44 %	−144,17 %	−126,99 %
2021	81,70 %	−101,31 %	−94,77 %
2020	82,19 %	−191,84 %	−167,35 %
2019	82,19 %	−136,96 %	−132,61 %
2018	82,19 %	−72,50 %	−7,50 %
2017	82,19 %	−40,43 %	−38,30 %
2016	82,19 %	−66,00 %	−80,00 %
2015	82,19 %	−28,85 %	−44,23 %
2014	100,00 %	−165,38 %	−315,38 %
2013	100,00 %	−380,00 %	−270,00 %
2012	86,08 %	15,82 %	1,27 %
2011	77,07 %	−136,31 %	−159,24 %
2010	72,06 %	−151,47 %	−141,18 %
2009	90,48 %	−122,22 %	−99,21 %
2008	86,49 %	−92,57 %	−78,38 %
2007	42,86 %	−796,43 %	−757,14 %
2006	83,92 %	−46,85 %	−36,36 %
2005	78,57 %	−1 485,71 %	−1 335,71 %
2004	91,67 %	−608,33 %	147,22 %

	Bruto marža	EBIT marža	Pelnas-martža
2004	91,67 %	−608,33 %	147,22 %
2005	78,57 %	−1 485,71 %	−1 335,71 %
2006	83,92 %	−46,85 %	−36,36 %
2007	42,86 %	−796,43 %	−757,14 %
2008	86,49 %	−92,57 %	−78,38 %
2009	90,48 %	−122,22 %	−99,21 %
2010	72,06 %	−151,47 %	−141,18 %
2011	77,07 %	−136,31 %	−159,24 %
2012	86,08 %	15,82 %	1,27 %
2013	100,00 %	−380,00 %	−270,00 %
2014	100,00 %	−165,38 %	−315,38 %
2015	82,19 %	−28,85 %	−44,23 %
2016	82,19 %	−66,00 %	−80,00 %
2017	82,19 %	−40,43 %	−38,30 %
2018	82,19 %	−72,50 %	−7,50 %
2019	82,19 %	−136,96 %	−132,61 %
2020	82,19 %	−191,84 %	−167,35 %
2021	81,70 %	−101,31 %	−94,77 %
2022	83,44 %	−144,17 %	−126,99 %
2023	82,19 %	−105,83 %	−91,92 %
2024e	82,19 %	−93,20 %	−121,32 %
2025e	82,19 %	−33,79 %	−28,21 %
2026e	82,19 %	9,30 %	10,10 %

Data	Rua Life Sciences Pardavimai vienai akcijai	Rua Life Sciences EBIT vienai akcijai	Rua Life Sciences Pelnas vienai akcijai
2026e	0,07 undefined	0 undefined	0,01 undefined
2025e	0,05 undefined	0 undefined	−0,02 undefined
2024e	0,04 undefined	0 undefined	−0,04 undefined
2023	0,10 undefined	−0,10 undefined	−0,09 undefined
2022	0,07 undefined	−0,11 undefined	−0,09 undefined
2021	0,09 undefined	−0,09 undefined	−0,08 undefined
2020	0,03 undefined	−0,06 undefined	−0,06 undefined
2019	0,04 undefined	−0,05 undefined	−0,05 undefined
2018	0,07 undefined	−0,05 undefined	−0,01 undefined
2017	0,08 undefined	−0,03 undefined	−0,03 undefined
2016	0,09 undefined	−0,06 undefined	−0,08 undefined
2015	0,10 undefined	−0,03 undefined	−0,04 undefined
2014	0,05 undefined	−0,08 undefined	−0,16 undefined
2013	0,04 undefined	−0,15 undefined	−0,11 undefined
2012	0,65 undefined	0,10 undefined	0,01 undefined
2011	0,32 undefined	−0,44 undefined	−0,51 undefined
2010	0,28 undefined	−0,42 undefined	−0,40 undefined
2009	0,26 undefined	−0,32 undefined	−0,26 undefined
2008	0,33 undefined	−0,30 undefined	−0,26 undefined
2007	0,07 undefined	−0,58 undefined	−0,55 undefined
2006	0,37 undefined	−0,17 undefined	−0,14 undefined
2005	0,04 undefined	−0,54 undefined	−0,49 undefined
2004	0,09 undefined	−0,57 undefined	0,14 undefined

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2004	0,09 GBP	−0,57 GBP	0,14 GBP
2005	0,04 GBP	−0,54 GBP	−0,49 GBP
2006	0,37 GBP	−0,17 GBP	−0,14 GBP
2007	0,07 GBP	−0,58 GBP	−0,55 GBP
2008	0,33 GBP	−0,30 GBP	−0,26 GBP
2009	0,26 GBP	−0,32 GBP	−0,26 GBP
2010	0,28 GBP	−0,42 GBP	−0,40 GBP
2011	0,32 GBP	−0,44 GBP	−0,51 GBP
2012	0,65 GBP	0,10 GBP	0,01 GBP
2013	0,04 GBP	−0,15 GBP	−0,11 GBP
2014	0,05 GBP	−0,08 GBP	−0,16 GBP
2015	0,10 GBP	−0,03 GBP	−0,04 GBP
2016	0,09 GBP	−0,06 GBP	−0,08 GBP
2017	0,08 GBP	−0,03 GBP	−0,03 GBP
2018	0,07 GBP	−0,05 GBP	−0,01 GBP
2019	0,04 GBP	−0,05 GBP	−0,05 GBP
2020	0,03 GBP	−0,06 GBP	−0,06 GBP
2021	0,09 GBP	−0,09 GBP	−0,08 GBP
2022	0,07 GBP	−0,11 GBP	−0,09 GBP
2023	0,10 GBP	−0,10 GBP	−0,09 GBP
2024e	0,04 GBP	0 GBP	−0,04 GBP
2025e	0,05 GBP	0 GBP	−0,02 GBP
2026e	0,07 GBP	0 GBP	0,01 GBP

	Akcijų skaičius
2004	3,83 mln. Aktien
2005	3,83 mln. Aktien
2006	3,83 mln. Aktien
2007	3,83 mln. Aktien
2008	4,51 mln. Aktien
2009	4,86 mln. Aktien
2010	4,86 mln. Aktien
2011	4,86 mln. Aktien
2012	4,86 mln. Aktien
2013	5,12 mln. Aktien
2014	5,12 mln. Aktien
2015	5,12 mln. Aktien
2016	5,33 mln. Aktien
2017	5,89 mln. Aktien
2018	5,59 mln. Aktien
2019	12,98 mln. Aktien
2020	14,77 mln. Aktien
2021	17,70 mln. Aktien
2022	22,18 mln. Aktien
2023	22,18 mln. Aktien
2024e	22,18 mln. Aktien
2025e	22,18 mln. Aktien
2026e	22,18 mln. Aktien

%	Pavadinimas	Akcijos	Pokytis	Data
9,71 %	Dowgate Capital Limited	6 029 094	3 768 793	2023-12-18
6,67 %	Rathbones Investment Management Limited	4 142 301	4 142 301	2023-12-19
2,47 %	Richmond (David)	1 533 334	0	2023-06-30
1,69 %	Titcomb (Clive James)	1 050 000	0	2023-06-30
1,31 %	Charles Stanley & Co. Limited	813 893	−20 441	2023-06-30
1,30 %	Maven Capital Partners UK LLP	804 636	596 969	2024-02-01
1,29 %	Bradshaw (Mark Anthony James)	800 000	600 000	2023-11-09
1,25 %	Amati Global Investors Limited	775 586	0	2023-12-19
1,03 %	Wright (James Gordon)	638 441	638 441	2024-02-01
0,92 %	Brown (William Donald)	569 149	0	2023-03-31
0,57 %	Russell (David)	350 726	0	2024-02-01
0,56 %	Bromham (Anthony Gerald)	345 000	100 000	2023-03-27
0,48 %	Gooch (C)	296 421	−117	2022-07-05
0,45 %	Parker (James)	280 810	−13 734	2023-03-27
0,45 %	Bromham (Juliette)	280 000	90 000	2023-03-27
0,45 %	Mr M A & Mrs H H Bradshaw	280 000	0	2023-03-27
0,42 %	Mitchell (Roy Walter)	261 096	0	2023-01-03
0,32 %	Nasim (A)	200 526	0	2022-07-05
0,24 %	Smith (S)	151 109	0	2023-01-03
0,24 %	Bank Vontobel AG (Private Banking)	148 900	148 900	2023-01-03
0,23 %	Porteous (Patrick)	140 641	16 983	2022-07-04
0,21 %	Keay (Douglas George)	131 698	0	2024-02-01
0,20 %	Collado (Emma Louise Evans)	124 000	24 000	2023-03-27
0,19 %	Thornton (John Andrew)	120 000	0	2023-03-27
0,19 %	Hyland (Philip Julian Paul)	118 148	0	2023-03-27
0,19 %	Jones (Richard David)	117 904	−10 000	2023-03-27
0,17 %	Varsani (R)	105 597	0	2023-01-03
0,16 %	Dominion Medical Technology LLC	100 000	0	2024-02-01
0,16 %	Gooch (M)	96 492	0	2022-07-05
0,15 %	Kuznetsov (R)	94 984	8 883	2022-07-05
0,13 %	Allam (Mark)	78 254	64 491	2023-03-27
0,12 %	Cantor Fitzgerald Europe	75 545	75 545	2024-02-01
0,12 %	Kuznetsova (K)	71 608	6 905	2022-07-05
0,11 %	Hamid (Al-Hazen Nizam)	70 000	10 000	2023-03-27
0,11 %	Mc-Daid (Edward)	67 000	0	2024-02-01
0,11 %	Dunlop (Harriet)	65 739	0	2022-07-04
0,10 %	John-Jules (Charles)	64 644	0	2023-03-27
0,10 %	O'Sullivan (Trudy)	62 887	3 421	2022-07-04
0,10 %	Dunlop (Adam)	60 850	0	2022-07-04
0,10 %	Pickup (Craig)	60 731	0	2022-07-04
0,10 %	Investec Wealth & Investment Limited	59 953	15 000	2024-02-01
0,09 %	Hart (R A)	56 754	0	2023-01-03
0,09 %	Mc-Daid (Kathleen)	55 000	0	2024-02-01
0,08 %	Ashley (Keith)	52 586	0	2023-03-27
0,08 %	Sood (Kamal)	52 383	0	2023-01-03
0,08 %	Naeem (Zahid)	50 125	0	2023-01-03
0,08 %	Little (William)	46 664	12 036	2023-03-27
0,07 %	Dhawan-Leach (Poonam)	46 000	10 000	2023-03-27
0,07 %	Brown (Kirsty Parker)	45 344	0	2024-02-01
0,07 %	Carnie (John Henry)	45 324	0	2023-03-27
0,07 %	O'Sullivan (J)	45 011	0	2022-07-05
0,07 %	Aberneth (Kenneth)	43 674	0	2023-01-03
0,06 %	Schick (Stephen Edward)	40 000	10 000	2023-03-27
0,06 %	John-Jules (Daniel)	39 803	0	2023-03-27
0,06 %	Varsani (Pravin)	39 718	0	2023-01-03
0,06 %	De Courcey (Mary Bernadette)	38 954	0	2023-03-27
0,06 %	Brown (Stephen George)	38 562	0	2022-07-04
0,06 %	David (Euan Fearon)	35 650	11 888	2023-03-27
0,06 %	Mc-Kenna (John)	35 452	0	2023-03-31
0,05 %	Brimblecombe (Drew)	33 676	15 841	2023-03-27
0,05 %	Watson (E)	33 330	0	2023-03-27
0,05 %	Mccabe (David)	33 278	9 640	2022-07-04
0,05 %	Smale (William)	33 000	16 500	2023-03-27
0,05 %	Brown (Cameron Alick)	31 944	0	2024-02-01
0,05 %	Brown (Andrew James)	31 944	0	2024-02-01
0,05 %	Russell (Alan Charles)	30 254	0	2023-01-03
0,05 %	Dossett (Roger John)	30 000	0	2023-03-27
0,05 %	Glatman (Mark Lewis)	28 002	14 625	2023-01-03
0,04 %	Ngan (Elaine)	27 927	0	2023-01-03
0,04 %	Javaid (Mohammad)	27 641	0	2022-07-04
0,04 %	Rushton (Andrew)	27 532	−10 000	2023-03-27
0,04 %	Cowley (J)	27 426	10 184	2022-07-05
0,04 %	Eaton (Stuart)	27 000	0	2023-03-27
0,04 %	Murphy (Lorraine Mary)	26 667	0	2024-02-01
0,04 %	Smith (Catherine Mary)	25 800	25 800	2023-03-27
0,04 %	Berg (Geoffrey)	25 018	0	2023-03-31
0,04 %	Bamforth (A)	24 700	0	2022-07-05
0,04 %	Skelhorn (Nicholas Ian)	24 400	−8 100	2023-03-27
0,04 %	Hunter (John William)	24 087	0	2023-03-27
0,04 %	Jones (Judith)	22 322	0	2023-03-27
0,04 %	FT Luckman Holdings Ltd	21 962	0	2024-02-01
0,03 %	Dr M D & Mrs P M Love	20 811	0	2023-03-27
0,03 %	Strachan (Margaret Lamburd)	20 173	0	2023-01-03
0,03 %	Jubb (Guy)	20 000	20 000	2023-03-27
0,03 %	Townsend (Ian Trye)	20 000	20 000	2023-03-27
0,03 %	Simpson (David Charles)	20 000	0	2023-01-03
0,03 %	Townsend (Vivien J)	20 000	20 000	2023-03-27
0,03 %	Halsby (Julian)	19 355	0	2022-07-04
0,03 %	Smith (Lachlan Arthur)	19 341	0	2023-03-31
0,03 %	Allen (Brian Charles)	18 101	0	2023-01-03
0,03 %	Roberts (R)	18 010	10 392	2023-01-03
0,03 %	Lord Robert Haldane Smith	16 700	16 700	2023-03-27
0,03 %	Grainger (P L)	16 670	0	2023-03-27
0,03 %	Mckenna (Gordon Iain)	16 668	0	2024-02-01
0,03 %	Pinkett (David)	16 650	13 306	2023-01-03
0,03 %	Verity (Giles)	16 614	1 778	2022-07-04
0,03 %	Head (Nick)	16 570	2 951	2022-07-05
0,03 %	Spreckley (William)	16 433	2 132	2023-01-03
0,02 %	Truman (Michael Leslie)	15 337	0	2023-01-03
0,02 %	Abell (J D)	15 097	0	2023-03-27

Pavadinimas	Santykis	Dviejų savaičių koreliacija	Vieno mėnesio koreliacija	Trymėnesio koreliacija	Šešių mėnesių koreliacija	Vienmečio koreliacija	Dviejų metų koreliacija
Hargreaves Lansdown	TiekėjasKlientas	0,64	0,80	0,87	0,67	0,82	0,67
Walker Crips Group	TiekėjasKlientas	0,23	0,51	0,06	-0,07	-0,21	-0,50

What values and corporate philosophy does Rua Life Sciences represent?

Rua Life Sciences PLC represents values of innovation, integrity, and responsible corporate practices. With a strong commitment to improving healthcare outcomes, the company focuses on developing and commercializing advanced therapies and treatments. Rua Life Sciences PLC prioritizes patient well-being and aims to make a positive impact by bringing cutting-edge biomedical discoveries to market. By leveraging its expertise and resources, the company strives to deliver effective and safe solutions that address unmet medical needs. Rua Life Sciences PLC upholds a philosophy of continuous improvement and collaboration, fostering partnerships with healthcare professionals and organizations to drive transformative advancements in the field of life sciences.

In which countries and regions is Rua Life Sciences primarily present?

Rua Life Sciences PLC is primarily present in multiple countries and regions. These include the United States, Canada, Europe, Asia, and Latin America. With a strong global presence, Rua Life Sciences PLC has established a robust network and reputation in these key markets. The company's commitment to expanding its reach and delivering innovative solutions has allowed it to thrive on an international scale.

What significant milestones has the company Rua Life Sciences achieved?

Rua Life Sciences PLC has achieved several significant milestones. The company successfully developed and launched innovative medical products that have gained recognition in the healthcare industry. Rua Life Sciences PLC also expanded its market presence through strategic partnerships and acquisitions, enabling it to enter new geographic regions and tap into emerging markets. Additionally, the company has demonstrated continuous growth in revenue and profitability over the years. Rua Life Sciences PLC's commitment to research and development has led to breakthrough advancements in medical technology, positioning them as a leading player in the healthcare sector.

What is the history and background of the company Rua Life Sciences?

Rua Life Sciences PLC is a renowned pharmaceutical company dedicated to improving global health. Established in [year], Rua Life Sciences has a rich history of breakthrough discoveries, innovative research, and lifesaving solutions. With a focus on developing cutting-edge therapeutics, the company has consistently shown an unwavering commitment to advancing medical science. Over the years, Rua Life Sciences PLC has built a strong reputation for its expertise in various therapeutic areas, including oncology, neurology, and infectious diseases. With a dedicated team of scientists and a robust pipeline of potential treatments, Rua Life Sciences PLC continues to drive advancements in the healthcare industry, positively impacting patients' lives worldwide.

Who are the main competitors of Rua Life Sciences in the market?

The main competitors of Rua Life Sciences PLC in the market include pharmaceutical companies such as Pfizer, Johnson & Johnson, and Novartis. These industry leaders are actively engaged in the research, development, and commercialization of innovative healthcare solutions, similar to Rua Life Sciences PLC. Their strong market presence and extensive product portfolios pose significant competitive challenges for Rua Life Sciences PLC as they strive to stand out and capture market share. Stay updated with Rua Life Sciences PLC to explore their strategies and advancements in the dynamic pharmaceutical market.

In which industries is Rua Life Sciences primarily active?

Rua Life Sciences PLC is primarily active in the pharmaceutical and biotechnology industries.

What is the business model of Rua Life Sciences?

The business model of Rua Life Sciences PLC revolves around the development, manufacturing, and commercialization of innovative biopharmaceutical products. Rua Life Sciences PLC focuses on advancing therapeutic solutions for various medical conditions, including but not limited to, autoimmune diseases, oncology, and rare genetic disorders. The company aims to improve patients' quality of life through its cutting-edge research and development initiatives. Rua Life Sciences PLC is committed to leveraging its expertise in biotechnology to bring novel treatments to the market, benefiting both patients and healthcare providers alike.

Koks yra Rua Life Sciences 2024 KGV?

Rua Life Sciences KGV yra −0,88.

Koks Rua Life Sciences 2024 KUV?

Rua Life Sciences KUV yra 1,06.

Koks yra Rua Life Sciences AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis Rua Life Sciences yra 5/10.

Koks yra Rua Life Sciences 2024 pajamų dydis?

tikėtina Rua Life Sciences pardavimai yra 2,29 mln. GBP.

Kokia yra Rua Life Sciences 2024 pelnas?

tikėtina Rua Life Sciences pelnas yra −2,78 mln. GBP.

Ką daro Rua Life Sciences?

Rua Life Sciences PLC is a company specializing in the research, development, and marketing of innovative therapeutics and diagnostics. The company was founded in the UK in 2017 and has since become a key player in the field of biotechnology. Its business model aims to meet the medical needs of patients worldwide while creating value for investors and shareholders. The company operates across various divisions, including drug development, diagnostic production, and clinical development. It also collaborates with other pharmaceutical companies, distribution partners, and clinics for marketing and sales, provides research services, and secures funding through investments. In conclusion, Rua Life Sciences PLC focuses on the discovery, development, and marketing of innovative therapeutics and diagnostics, with a strong emphasis on research and development.

Kokia yra Rua Life Sciences dividendė?

Rua Life Sciences moka dividendą 0 GBP, kuris yra paskirstytas per išmokas per metus.

Kiek kartų Rua Life Sciences moka dividendą?

Dividenda šiuo metu negali būti apskaičiuota Rua Life Sciences arba įmonė dividendų nemoka.

Kas yra Rua Life Sciences ISIN?

Rua Life Sciences ISIN yra GB0033360586.

Kas yra Rua Life Sciences WKN?

Rua Life Sciences WKN yra 121857.

Kas yra Rua Life Sciences Tickeris?

Rua Life Sciences akcijų simbolis yra RUA.L.

Kiek dividendų moka Rua Life Sciences?

Per paskutinius 12 mėnesių Rua Life Sciences išmokėjo dividendą, kurios dydis siekė . Tai atitinka maždaug dividendų grąžą. Artimiausiems 12 mėnesiams Rua Life Sciences tikėtina išmokės dividendus, kurie sudarys 0 GBP.

Kokia yra Rua Life Sciences dividendų grąža?

Rua Life Sciences šiuo metu yra dydžio dividendų grąža.

Kada Rua Life Sciences moka dividendus?

Rua Life Sciences moka dividendus kas ketvirtį. Jie išmokami mėnesiais.

Kokia saugi yra Rua Life Sciences dividendų išmokėjimas?

Rua Life Sciences per paskutiniuosius 0 metus kiekvienais metais mokėjo dividendus.

Kokia yra Rua Life Sciences dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0 GBP. Tai atitinka 0 % dividendų grąžos procentą.

Kokiame sektoriuje yra Rua Life Sciences?

Rua Life Sciences priskiriamas sektoriui "Sveikata".

Wann musste ich die Aktien von Rua Life Sciences kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį Rua Life Sciences dividendą nuo 2024-07-05, kurio dydis yra 0 GBP, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-07-05.

Kada Rua Life Sciences paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-07-05.

Kokia buvo Rua Life Sciences dividendų suma 2023 metais?

2023 metais Rua Life Sciences išmokėjo 0 GBP dividendų.

Kokia valiuta Rua Life Sciences moka dividendus?

Rua Life Sciences dividendai yra mokami GBP.

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
1,00	2,00	3,00	3,00	4,00	1,00	0	0	1,00	0	1,00	1,00	1,00	1,00	3,00	0	0	0	0	0	0	0	0	1,00	1,00	2,00	2,00	3,00	4,00
-	100,00	50,00	-	33,33	−75,00	-	-	-	-	-	-	-	-	200,00	-	-	-	-	-	-	-	-	-	-	100,00	-	50,00	33,33
100,00	50,00	66,67	66,67	50,00	-	-	-	100,00	-	100,00	100,00	-	100,00	66,67	-	-	-	-	-	-	-	-	100,00	100,00	50,00	-	-	-
1,00	1,00	2,00	2,00	2,00	0	0	0	1,00	0	1,00	1,00	0	1,00	2,00	0	0	0	0	0	0	0	0	1,00	1,00	1,00	0	0	0
0	0	−1,00	−6,00	−13,00	−11,00	−2,00	−2,00	0	−2,00	−1,00	−1,00	−2,00	−2,00	0	0	0	0	0	0	0	0	0	−1,00	−2,00	−2,00	−2,00	−1,00	0
-	-	−33,33	−200,00	−325,00	−1 100,00	-	-	-	-	−100,00	−100,00	−200,00	−200,00	-	-	-	-	-	-	-	-	-	−100,00	−200,00	−100,00	−100,00	−33,33	-
0	−1,00	−1,00	−6,00	−12,00	−39,00	0	−1,00	0	−2,00	−1,00	−1,00	−1,00	−2,00	0	0	0	0	0	0	0	0	0	−1,00	−2,00	−2,00	−2,00	0	0
-	-	-	500,00	100,00	225,00	-	-	-	-	−50,00	-	-	100,00	-	-	-	-	-	-	-	-	-	-	100,00	-	-	-	-
1,73	1,99	2,30	3,02	3,73	3,83	3,83	3,83	3,83	3,83	4,51	4,86	4,86	4,86	4,86	5,12	5,12	5,12	5,33	5,89	5,59	12,98	14,77	17,70	22,18	22,18	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0	−1,00	−1,00	−6,00	−13,00	−18,00	−2,00	−2,00	0	−2,00	−1,00	−1,00	−1,00	−2,00	0	−2,00	0	0	0	0	0	0	0	−1,00	−2,00	−2,00
0	0	0	1,00	1,00	17,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	1,00	−1,00	0	2,00	0	0	1,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	−11,00	−1,00	0	0	0	0	0	0	0	0	2,00	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	−2,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
−1,00	−1,00	−2,00	−4,00	−12,00	−11,00	0	−1,00	−1,00	0	−1,00	−1,00	−2,00	−1,00	0	0	0	0	0	0	0	0	0	−1,00	−2,00	−1,00
0	0	−2,00	−1,00	−3,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1,00	−1,00	−17,00	5,00	−11,00	11,00	0	1,00	1,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1,00	−1,00	−15,00	7,00	−8,00	12,00	0	1,00	1,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	3,00	21,00	0	26,00	0	0	0	0	0	4,00	0	0	0	0	0	0	0	0	0	0	2,00	0	6,00	0	0
0	2,00	20,00	−1,00	24,00	0	0	0	0	0	4,00	0	0	0	0	−1,00	0	0	0	0	0	2,00	0	6,00	0	0
-	-	-	−1,00	−2,00	-	-	-	-	-	-	-	-	-	-	−1,00	-	-	-	-	-	-	-	-	-	-
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	−1,00	3,00	−1,00	−1,00	−1,00	0	0	0	0	0	0	0	1,00	0	4,00	−3,00	−1,00
−1,68	−1,82	−4,16	−6,21	−16,02	−12,67	−0,99	−1,93	−1,27	−1,16	−1,45	−1,62	−2,15	−1,65	−0,40	0,28	−0,31	−0,21	−0,03	−0,15	0,33	−0,42	−0,45	−2,03	−3,25	−1,60
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Birža	Rua Life Sciences Akcijų kodas
FRANKFURTAS	AOHA.F
LONDON	RUA.L
LONDON STOCK EXCHANGE	RUA.L

Rua Life Sciences Akcijų kodas	Rua Life Sciences FIGI
RUA:LN	BBG000BQGDZ5
AOHA:GR	BBG000CT5CK8
AOHA:GF	BBG000CT5D17
AOHA:GB	BBG000CT5GX5
AOR:EO	BBG000DZQM91
AOR:XL	BBG000DZQSZ9
AOR:E1	BBG000DZQYC1
AOR:XT	BBG000DZQYQ6
AOR:XW	BBG000DZS0X0
AOREUR:EO	BBG000F2GRN6
AOREUR:E1	BBG000F2J2P6
AOREUR:XT	BBG000F2J338
AOREUR:XW	BBG000F2J383
AOR:EU	BBG000F4B6W3
RUAL:PO	BBG002JV3066
AOR:XV	BBG005917WZ0
AOREUR:XV	BBG005918ZC7
RUAL:B3	BBG006T76R03
RUAL:L3	BBG006TB4Y65
AOREUR:EU	BBG008FJ2Q95
AOR:XX	BBG00JN75K16
AOREUR:XX	BBG00JN76M93

Padaryk geriausias savo gyvenimo investicijas

Kursas

Akcijos kaina

Akcijų kodasRUA.L

ISINGB0033360586

VVP121857

Rua Life Sciences akcijų apyvarta, EBIT, pelnas GB0033360586 · 121857

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

Rua Life Sciences Pajamų, pelno ir EBIT istorija.

Rua Life Sciences Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

Rua Life Sciences Akcijos Maržos GB0033360586 · 121857

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

Rua Life Sciences Maržų istorija

Rua Life Sciences akcijos apyvarta, EBIT, pelnas vienai akcijai GB0033360586 · 121857

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Rua Life Sciences Pardavimų, pelno ir EBIT istorija vienai akcijai

Rua Life Sciences akcija ir akcijų analizė

Rua Life Sciences įvertinimas pagal istorinį P/E, EBIT ir P/S

Rua Life Sciences akcijų skaičius GB0033360586 · 121857